A study for assessment of HER2 status using Gene-Protein Assay (GPA) in metastatic colorectal cancer

A study for assessment of HER2 status using Gene-Protein Assay (GPA) in metastatic colorectal cancer - A study for assessment of HER2 status using Gene-Protein Assay (GPA) in metastatic colorectal cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039751

Enrollment

150

Registered

2020-03-10

Start date

2019-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A. the patients who is registered HER2 screening study and express a consent of secondary use of specimen.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
A concordance of HER2 status assessment between GPA and IHC/FISH	—

Countries

Japan,North America

Contacts

Public ContactYoshiaki Nakamura

National Cancer Center Hospital East Department of Gastroenterology and Gastrointestinal oncology

yoshinak@east.ncc.go.jp+81-4-7133-1111

Outcome results